Clinical platforms zero in on safety

KEM Clinicals is an update of Ariana Pharmas' Knowledge Extraction and Management platform, a decision-support tool for drug researchers. The new version supports clinical development and safety processes.

The update allows users to test hypotheses, and it generates them consistent with data relevant to trial objectives, according to an announcement. The solution uses such features as optimal inclusion/exclusion criteria in protocol design; early adverse event detection and characterization; identification of surrogate endpoints; and design of composite efficacy/safety endpoints.

Separately, TheraDoc has added six clinical and adverse drug event alert packages to its Expert System informatics platform. The alert bundles work with the platform to provide electronic surveillance of patient data from multiple hospital information sources.

- here's the KEM Clinicals release
- see the TheraDocs announcement

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.